METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

12724652

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to methods and formulations for treating, modifying, and/or managing gastrointestinal secretion, and intestinal conditions that cause the same. Methods of using at least one α3 β4 nAChR antagonist and formulations comprising at least one α3 β4 nAChR antagonist, or pharmaceutically acceptable salt thereof, are included.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AGI THERAPEUTICS PUBLIC LIMITED COMPANYADELAIDE CHAMBERS PETER STREET DUBLIN 8

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Devane, John Roscommon, IE 46 371

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation